TheEdgeResearch
Home / Stocks / RPNRF

Rapid Nutrition PLC (RPNRF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$10.00 ▲ +99900.00%
Market Cap
$4.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.25
52-Wk Range
0.01-10000
CEO
Simon Ledger
Country
GB
Currency
USD

Rapid Nutrition PLC operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mildenhall, GB. The stock last traded at $10.00, up 99900.00% on the session, giving a market capitalisation of $4.7M. On trailing twelve-month figures it carries a trailing P/E of -4.73, a net margin of -1591.6%. Its beta of -0.25 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-4.73
Price / Sales
34.01
Price / Book
0.79
EV / EBITDA
0.64
Gross margin
2.2%
Operating margin
-1343.2%
Net margin
-1591.6%
Return on equity
—
Debt / equity
0.01
Current ratio
18.68
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
12
IPO date
2019-03-28
Headquarters
Mildenhall, GB
About Rapid Nutrition PLC

Rapid Nutrition PLC is a natural healthcare enterprise that specializes in the research, development, and manufacture of a diverse array of scientifically-formulated health and wellness products. The company boasts a global presence, with operations spanning the United Kingdom, Australia, Asia, the United States, and beyond. Its offerings include organic and natural, science-backed dietary supplements, marketed under the SystemLS and Leisa's Secret brands. Furthermore, Rapid Nutrition provides oral antiviral therapies specifically designed to help combat both influenza and the common cold, which are sold under the Azurene brand. Established in 2001, the firm is headquartered in London, United Kingdom.

Comparable companies

Rapid Nutrition PLC is most often compared with the following Healthcare names:

AUSAFAVTBFBBRRFCANNCPIVFIONKFMVMDFRVVQFSEHCFTHCBF
More research on RPNRF
RPNRF technical analysis RPNRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →